Full-Time

Automation Controls Engineer 3

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

No salary listed

Springfield, MO, USA

In Person

Bachelor's

Category
Electrical Engineering (1)

Get referred to Curia

See people who can refer or advise you

Requirements
  • Bachelor's degree in Electrical, Chemical, Mechanical Engineering, or a related engineering discipline
  • 5 to 7 years of industrial experience in control engineering, systems integration, or a similar role, with a preference for regulated environments such as pharmaceutical, biotechnology, food and beverage, or consumer health manufacturing
  • Demonstrated experience designing and developing automation control systems, including Siemens and SCADA platforms
  • Solid understanding of instrumentation and controls (I&C), field instrumentation, and control panel design
  • Proficiency with engineering documentation including P&IDs, process flow diagrams, and SOPs
  • Familiarity with machine safety applications and electrical power distribution
  • Strong written and verbal communication skills, including the ability to produce technical reports and deliver group presentations
  • Ability to manage multiple projects and priorities simultaneously
  • Knowledge of applicable regulatory agencies and standards (OSHA, EPA, FDA, EU, JP, etc.)
  • Proficiency in Microsoft Office Suite (Word, Excel, Outlook, Access)
Responsibilities
  • Lead automation and controls projects from concept development, design, and specification through installation, commissioning, validation, and start-up
  • Develop project scopes, technical specifications, budgets, schedules, and resource plans to ensure successful project execution
  • Prepare and manage project budgets, ensuring activities remain within established guidelines, budget, and schedule
  • Manage relationships with equipment vendors, system integrators, contractors, and clients throughout the project lifecycle
  • Coordinate and oversee the work of outside trade firms, technical contractors, and equipment vendors
  • Conduct design reviews, risk assessments, and change control activities to ensure compliance with safety, quality, and regulatory requirements
  • Communicate project status and progress to stakeholders throughout the project lifecycle
  • Support engineering documentation including SOPs, PMs, P&IDs, process flow diagrams, and other technical documents
  • Design and develop automation control systems and produce associated project documentation and drawings to meet customer requirements
  • Configure software and hardware packages in alignment with client design specifications
  • Program PLCs (Allen-Bradley, Rockwell, Siemens) and HMI/SCADA systems (FactoryTalk)
  • Diagnoses and troubleshoot automation and control system issues, collaborating with internal teams, clients, and vendors to identify root causes and implement effective solutions
  • Manage site construction, installation, commissioning, and start-up support for integrated control systems
  • Validate and commission facility systems following established execution protocols, ensuring successful turnover to the customer
  • Identify and initiate projects for electrical and control system improvements within established guidance
  • Validate and commission facility systems following established execution protocols and ensure a successful turnover of the system to the customer.
  • Perform all documentation in compliance with ALCOA++ principles and site SOPs.
  • Adhere to applicable cGMP documents including SOPs, batch records, protocols, change controls, and controlled forms.
  • Keep all required cGMP training current and escalate quality concerns along with proposed solutions to the Quality department.
Desired Qualifications
  • PLC (Allen-Bradley) certifications and continuing education credits
  • Experience with building management systems and cleanroom/aseptic facility design

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Curia expanded Glasgow sterile drug product capacity in March 2026.
  • Curia completed a $4 million sterile API upgrade in Valladolid in October 2025.
  • Curia won a 2025 CDMO Leadership Award in Global Biologics.

What critics are saying

  • Curia is closing Burlington in 2026 and cutting 81 jobs.
  • Curia is working on an out-of-court restructuring with private credit lenders.
  • Asset sales like Pace’s New Jersey lab purchase signal continued portfolio shrinkage.

What makes Curia unique

  • Curia spans discovery through commercial manufacturing across small molecules and biologics.
  • Curia manufactures mRNA and self-replicating RNA, including Replicate Bioscience’s RBI-4000.
  • Curia runs 20+ global sites with sterile fill-finish and cell-line development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.